Sentien Biotechnologies is a biotechnology company developing cell therapies to restore balance to the immune system. It develops blood conditioning systems to treat systemic inflammatory diseases. Sentien’s SBI-101 product is designed to allow for controlled, sustained delivery of mesenchymal stromal cell (MSC) secreted factors.